Ojemda (tovorafenib) Tablets and Oral Suspension

Ojemda is a prescription medicine used to treat Low-Grade Glioma. FDA approved tovorafenib (brand name Ojemda) is not (yet) registered or available in India but on request Indian patient can buy Ojemda at the lowest price.

Ojemda-available-india
Ojemda (tovorafenib) Tablets and Oral Suspension

Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!

For Indian Patient Enquiry under NPP.

For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.

Ojemda (tovorafenib) Tablets and Oral Suspension

Tovorafenib is indicated for the treatment of people six months of age and older with relapsed or refractory pediatric low-grade glioma harboring a BRAF fusion or rearrangement, or BRAF V600 mutation.

OJEMDA is a kinase inhibitor that is used to treat patients 6 months of age and older with relapsed or refractory pediatric low-grade glioma (LGG) harboring a BRAF fusion or rearrangement or BRAF V600 mutation.

Tovorafenib is indicated for the treatment of people six months of age and older with relapsed or refractory pediatric low-grade glioma harboring a BRAF fusion or rearrangement, or BRAF V600 mutation.

Tovorafenib was approved for medical use in the United States in April 2024, and is the first approval of a systemic therapy for the treatment of people with pediatric low-grade glioma with BRAF rearrangements, including fusions.

NDA 218033
Drug Name: Ojemda
Active Ingredient: tovorafenib
Approval Date: 4/23/2024
FDA-approved use on approval date: To treat relapsed or refractory pediatric low-grade glioma
Company: Day One Biopharmaceuticals Inc.

Dosage Forms And Strengths:
Tablets: 100 mg
For Oral Suspension: 25 mg/mL

For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here

Alleviare Life Sciences

About Us

Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.

Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.

Alleviare India, a certified pharmaceutical facilitator / supplier / importer of specialty medicines or drugs based in India.